ProBioGenCancer vaccinesTransgene and ProBioGen forge partnershipLatest NewsThe Strasbourg-based biotech company Transgene and the Berlin-based CDMO ProBioGen have entered into a licensing agreement to collaboratively advance the development of individualised cancer vaccines. Read more 5 November 2024 https://european-biotechnology.com/wp-content/uploads/2024/11/tk.de_ProBioGen_Cell_Line_AGE1.CR_.PIX_Kryolager_Resized.webp 541 960 Christian Kähler /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Christian Kähler2024-11-05 18:09:512024-11-06 09:32:00Transgene and ProBioGen forge partnership